Form 4 holding
Chairman and CEO, Director, 10%+ Owner
CASI Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 644,553
- Estimated value
- Report date
- 15 Jun 2022
- Price
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|